Aveanna Healthcare completed the acquisition of Family First Homecare for $175.5 million, a multi-state pediatric home care provider. The deal prompted the company to raise its fiscal 2026 revenue guidance to $2.63-$2.65 billion (from $2.56-$2.58 billion) and adjusted EBITDA guidance to $338-$342 million (from $328-$332 million), with Family First contributing $70 million in revenue and $10 million in EBITDA.

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) completed its acquisition of Family First Homecare, a multi-state pediatric home care provider, for $175.5 million in cash. The acquisition adds 27 locations across seven states and expands Aveanna's specialized care footprint. The company updated its full year 2026 guidance, raising revenue guidance to $2.63-$2.65 billion (from $2.56-$2.58 billion) and Adjusted EBITDA guidance to $338-$342 million (from $328-$332 million), with Family First Homecare contributing $70 million in revenue and $10 million in Adjusted EBITDA.

Summit Partners sold 2.1 million shares of Aveanna Healthcare (AVAH) worth approximately $16.23 million in Q1 2026, reducing its stake to 5.23% of AUM. Despite the 23% year-over-year stock price increase, the sale appears to be profit-taking rather than a loss of confidence, as Aveanna posted strong 2025 results with 20.2% revenue growth to $2.43 billion and 75% EBITDA surge.

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced an agreement to acquire Family First Homecare, a multi-state pediatric home care provider with 27 locations across seven states. The acquisition expands Aveanna's specialized care services and geographic footprint. The transaction is expected to close in Q2 2026 and will be funded through cash on hand and existing credit facilities.

Aveanna Healthcare's Home Health and Hospice division received CHAP Disease Program Certification for Heart Failure, demonstrating compliance with industry's highest standards. The certification recognizes Aveanna's Heartways program, a scientifically validated care initiative that improves outcomes for heart disease patients through comprehensive education, symptom monitoring, and palliative care protocols.

Patrick Cunningham, chief compliance officer of Aveanna Healthcare, sold 36,015 shares worth $292,488 between December 30 and January 2. The sale represented 10.93% of his direct holdings but was driven by tax obligations from vested equity awards rather than discretionary selling. Despite the insider sale, the company is experiencing strong operational momentum with Q3 revenue up 22.2% and adjusted EBITDA surging 67.5%, with shares up 99% over the past year.

Aveanna Healthcare Holdings will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 14, 2026, offering a presentation and investor meetings.

Aveanna Healthcare Holdings will virtually attend the BofA Securities Home Care Conference on December 9, 2025, presenting at 12:30pm EST and hosting investor meetings.

Aveanna Healthcare Holdings is conducting a secondary offering of 10 million shares at $9.00 per share, with selling stockholders receiving all net proceeds. The offering is managed by multiple investment banks and expected to settle on October 23, 2025.

Aveanna Healthcare Holdings Inc. announced its management team will attend the Deutsche Bank Annual Leveraged Finance Conference in Austin, TX on October 15, 2025, and host investor meetings.

Aveanna Healthcare Holdings Inc. has completed the acquisition of Thrive Skilled Pediatric Care, LLC, a leading provider of pediatric home care services. The combination creates an enhanced footprint for Aveanna and expands its specialized care model.

Aveanna Healthcare Holdings Inc. has entered into an agreement to acquire Thrive Skilled Pediatric Care, one of the largest independent providers of pediatric home care. The combination will enhance Aveanna's footprint in existing states and introduce its specialized care model into two new states.